Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.

Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Abstract Text:

Robert U Svensson,J Matthew Barnes,Oskar W Rokhlin,Michael B Cohen,Michael D Henry,

Bioluminescence imaging is widely used to evaluate tumor growth and response to therapy in living animals. In cells expressing luciferase under the control of a constitutive promoter, light output in part depends on viable cell number, so that changes in bioluminescence intensity may be correlated with changes in viable tumor mass over time. We have found that treatment of cancer cell lines expressing luciferase under control of the cytomegalovirus (CMV) promoter with staurosporine, doxorubicin, and paclitaxel results in a transient increase in bioluminescence, which is positively correlated with apoptosis and inversely correlated with cell viability. In contrast, similar treatment of cell lines expressing luciferase under control of the SV40 promoter did not exhibit this result. We found that low doses of staurosporine induced bioluminescence in CMV- but not SV40-driven luciferase cell lines, whereas high doses elicited induction in both, indicating promoter-dependent and promoter-independent mechanisms of bioluminescence induction. The promoter-dependent increase in bioluminescence intensity from CMV-driven luciferase is a result of induction of luciferase mRNA and protein expression. We extended these findings in vivo; doxorubicin treatment resulted in a transient induction in bioluminescence when normalized to tumor volume in CMV- but not SV40-driven luciferase-expressing xenografts. We found that inhibition of the p38 mitogen-activated protein kinase pathway blocked bioluminescence induction by doxorubicin, paclitaxel, and staurosporine in CMV-driven luciferase-expressing cells. These findings have important implications when using bioluminescence to monitor the efficacy of anticancer therapy and underscore the complex regulation of the CMV promoter, which is widely used for high-level protein expression in mammalian cells.

Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Publishing Authors By Initials

RU Svensson,JM Barnes,OW Rokhlin,MB Cohen,MD Henry,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer research

VOLUME: 67

Page Numbers: 10445-54

Journal Abbreviation: Cancer Res.

ISSN: 1538-7445

DAY: 1

MONTH: Nov

YEAR: 2007

Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2984705

Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.

AFFILIATION: Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52240, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy Related Publications

• A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer.
• Arabidopsis kinome: after the casting.
• Can a universal influenza immunization program reduce emergency department volume?
• Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.
• Comparison of diffuse reflectance fourier transform mid-infrared and near-infrared spectroscopy with grating-based near-infrared for the determination of fatty acids in forages.
• Detecting estrus in synchronized heifers-using tailpaint and an aerosol raddle.
• Diffusion tensor MR imaging tractography of the pyramidal tracts correlates with clinical motor function in children with congenital hemiparesis.
• Effect of amendment C:N ratio on plant richness, cover and metal content for acidic Pb and Zn mine tailings in Leadville, Colorado.
• Failed extubation in the neonatal intensive care unit.
• Fatty acid methyl esters in grasshopper eggs.
• Identifying risk factors for postpartum tobacco use.
• Integrated membrane filters for minimizing hydrodynamic flow and filtering in microfluidic devices.
• Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
• Long term outcomes following iodine-125 monotherapy for localized prostate cancer: the cookridge 10 year results.
• Nasal catheter insertion for suction diathermy adenoidectomy.
• Noninvasive methods to identify early vascular access dysfunction.
• On the reliability of (13)C metabolic modeling with two-compartment neuronal-glial models.
• Regulation of 1D-myo-inositol-3-phosphate synthase in yeast.
• Retinoblastoma protein regulation by the COP9 signalosome.
• Role of glycogen synthase kinase-3 alpha in insulin action in cultured human skeletal muscle cells.
• Solamargine: The Main Glycoalkaloid from the Fruits of Solanum paludosum.
• Spectroscopic imaging with volume selection by unpaired adiabatic pi pulses: Theory and application.
• TRPM8 Axonal expression is decreased in painful human teeth with irreversible pulpitis and cold hyperalgesia.
• The emergence of yeast lipidomics.
• The grammatical morpheme deficit in moderate hearing impairment.
• The protein kinase CK2 phosphorylates SNAP190 to negatively regulate SNAPC DNA binding and human U6 transcription by RNA polymerase III.
• The unorthodox SNAP50 zinc finger domain contributes to cooperative promoter recognition by human SNAPC.
• Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue.
• Undoing the misdescription of medicine.
• [Group therapy through graphic art.]